Global Ultrasonic Microbubble Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Ultrasonic Microbubble Contrast Agents market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ultrasonic Microbubble Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Ultrasonic Microbubble Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Ultrasonic Microbubble Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Ultrasonic Microbubble Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Ultrasonic Microbubble Contrast Agents include Bayer, Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Miltenyi Biotec, NanoPET Pharma and POINTbiomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ultrasonic Microbubble Contrast Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Ultrasonic Microbubble Contrast Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Ultrasonic Microbubble Contrast Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ultrasonic Microbubble Contrast Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Ultrasonic Microbubble Contrast Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Ultrasonic Microbubble Contrast Agents sales, projected growth trends, production technology, application and end-user industry.

Ultrasonic Microbubble Contrast Agents Segment by Company

Bayer
Bracco
GE Healthcare
ImaRx Therapeutics
Lantheus Medical Imaging
Microvascular Therapeutics
Miltenyi Biotec
NanoPET Pharma
POINTbiomedical
Feiruida Medical
Fuman Group
Runkun Pharmaceutical
Lizhuo Pharmaceutical
Qi-hui Biopharmaceutical
SUNΛ Med-Engineering
Starleaf
Ultrasonic Microbubble Contrast Agents Segment by Type

Liposome Envelope
Multimer-based Envelope
Albumin-based Envelope
Others
Ultrasonic Microbubble Contrast Agents Segment by Application

Angiographic Ultrasonography
Cardiac Ultrasonography
Liver Ultrasonography
Others
Ultrasonic Microbubble Contrast Agents Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasonic Microbubble Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ultrasonic Microbubble Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasonic Microbubble Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ultrasonic Microbubble Contrast Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ultrasonic Microbubble Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ultrasonic Microbubble Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ultrasonic Microbubble Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Ultrasonic Microbubble Contrast Agents Market Size, 2020 VS 2024 VS 2031
1.3 Global Ultrasonic Microbubble Contrast Agents Market Size Estimates and Forecasts (2020-2031)
1.4 Global Ultrasonic Microbubble Contrast Agents Sales Estimates and Forecasts (2020-2031)
1.5 Global Ultrasonic Microbubble Contrast Agents Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Ultrasonic Microbubble Contrast Agents Market Dynamics
2.1 Ultrasonic Microbubble Contrast Agents Industry Trends
2.2 Ultrasonic Microbubble Contrast Agents Industry Drivers
2.3 Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges
2.4 Ultrasonic Microbubble Contrast Agents Industry Restraints
3 Ultrasonic Microbubble Contrast Agents Market by Manufacturers
3.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Manufacturers (2020-2025)
3.2 Global Ultrasonic Microbubble Contrast Agents Sales by Manufacturers (2020-2025)
3.3 Global Ultrasonic Microbubble Contrast Agents Average Sales Price by Manufacturers (2020-2025)
3.4 Global Ultrasonic Microbubble Contrast Agents Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Ultrasonic Microbubble Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Ultrasonic Microbubble Contrast Agents Manufacturers, Product Type & Application
3.7 Global Ultrasonic Microbubble Contrast Agents Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Ultrasonic Microbubble Contrast Agents Market CR5 and HHI
3.8.2 Global Top 5 and 10 Ultrasonic Microbubble Contrast Agents Players Market Share by Revenue in 2024
3.8.3 2024 Ultrasonic Microbubble Contrast Agents Tier 1, Tier 2, and Tier 3
4 Ultrasonic Microbubble Contrast Agents Market by Type
4.1 Ultrasonic Microbubble Contrast Agents Type Introduction
4.1.1 Liposome Envelope
4.1.2 Multimer-based Envelope
4.1.3 Albumin-based Envelope
4.1.4 Others
4.2 Global Ultrasonic Microbubble Contrast Agents Sales by Type
4.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Ultrasonic Microbubble Contrast Agents Sales by Type (2020-2031)
4.2.3 Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2020-2031)
4.3 Global Ultrasonic Microbubble Contrast Agents Revenue by Type
4.3.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Type (2020-2031)
4.3.3 Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2020-2031)
5 Ultrasonic Microbubble Contrast Agents Market by Application
5.1 Ultrasonic Microbubble Contrast Agents Application Introduction
5.1.1 Angiographic Ultrasonography
5.1.2 Cardiac Ultrasonography
5.1.3 Liver Ultrasonography
5.1.4 Others
5.2 Global Ultrasonic Microbubble Contrast Agents Sales by Application
5.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Ultrasonic Microbubble Contrast Agents Sales by Application (2020-2031)
5.2.3 Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2020-2031)
5.3 Global Ultrasonic Microbubble Contrast Agents Revenue by Application
5.3.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Application (2020-2031)
5.3.3 Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application (2020-2031)
6 Global Ultrasonic Microbubble Contrast Agents Sales by Region
6.1 Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Ultrasonic Microbubble Contrast Agents Sales by Region (2020-2031)
6.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Region (2020-2025)
6.2.2 Global Ultrasonic Microbubble Contrast Agents Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Ultrasonic Microbubble Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Ultrasonic Microbubble Contrast Agents Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Ultrasonic Microbubble Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Ultrasonic Microbubble Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Ultrasonic Microbubble Contrast Agents Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Ultrasonic Microbubble Contrast Agents Revenue by Region
7.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Region
7.1.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Region (2020-2025)
7.1.3 Global Ultrasonic Microbubble Contrast Agents Revenue by Region (2026-2031)
7.1.4 Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Ultrasonic Microbubble Contrast Agents Revenue (2020-2031)
7.2.2 North America Ultrasonic Microbubble Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Ultrasonic Microbubble Contrast Agents Revenue (2020-2031)
7.3.2 Europe Ultrasonic Microbubble Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Ultrasonic Microbubble Contrast Agents Revenue (2020-2031)
7.4.2 Asia-Pacific Ultrasonic Microbubble Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Bayer
8.1.1 Bayer Comapny Information
8.1.2 Bayer Business Overview
8.1.3 Bayer Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio
8.1.5 Bayer Recent Developments
8.2 Bracco
8.2.1 Bracco Comapny Information
8.2.2 Bracco Business Overview
8.2.3 Bracco Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio
8.2.5 Bracco Recent Developments
8.3 GE Healthcare
8.3.1 GE Healthcare Comapny Information
8.3.2 GE Healthcare Business Overview
8.3.3 GE Healthcare Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio
8.3.5 GE Healthcare Recent Developments
8.4 ImaRx Therapeutics
8.4.1 ImaRx Therapeutics Comapny Information
8.4.2 ImaRx Therapeutics Business Overview
8.4.3 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
8.4.5 ImaRx Therapeutics Recent Developments
8.5 Lantheus Medical Imaging
8.5.1 Lantheus Medical Imaging Comapny Information
8.5.2 Lantheus Medical Imaging Business Overview
8.5.3 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio
8.5.5 Lantheus Medical Imaging Recent Developments
8.6 Microvascular Therapeutics
8.6.1 Microvascular Therapeutics Comapny Information
8.6.2 Microvascular Therapeutics Business Overview
8.6.3 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
8.6.5 Microvascular Therapeutics Recent Developments
8.7 Miltenyi Biotec
8.7.1 Miltenyi Biotec Comapny Information
8.7.2 Miltenyi Biotec Business Overview
8.7.3 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio
8.7.5 Miltenyi Biotec Recent Developments
8.8 NanoPET Pharma
8.8.1 NanoPET Pharma Comapny Information
8.8.2 NanoPET Pharma Business Overview
8.8.3 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio
8.8.5 NanoPET Pharma Recent Developments
8.9 POINTbiomedical
8.9.1 POINTbiomedical Comapny Information
8.9.2 POINTbiomedical Business Overview
8.9.3 POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio
8.9.5 POINTbiomedical Recent Developments
8.10 Feiruida Medical
8.10.1 Feiruida Medical Comapny Information
8.10.2 Feiruida Medical Business Overview
8.10.3 Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio
8.10.5 Feiruida Medical Recent Developments
8.11 Fuman Group
8.11.1 Fuman Group Comapny Information
8.11.2 Fuman Group Business Overview
8.11.3 Fuman Group Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio
8.11.5 Fuman Group Recent Developments
8.12 Runkun Pharmaceutical
8.12.1 Runkun Pharmaceutical Comapny Information
8.12.2 Runkun Pharmaceutical Business Overview
8.12.3 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
8.12.5 Runkun Pharmaceutical Recent Developments
8.13 Lizhuo Pharmaceutical
8.13.1 Lizhuo Pharmaceutical Comapny Information
8.13.2 Lizhuo Pharmaceutical Business Overview
8.13.3 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
8.13.5 Lizhuo Pharmaceutical Recent Developments
8.14 Qi-hui Biopharmaceutical
8.14.1 Qi-hui Biopharmaceutical Comapny Information
8.14.2 Qi-hui Biopharmaceutical Business Overview
8.14.3 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
8.14.5 Qi-hui Biopharmaceutical Recent Developments
8.15 SUNΛ Med-Engineering
8.15.1 SUNΛ Med-Engineering Comapny Information
8.15.2 SUNΛ Med-Engineering Business Overview
8.15.3 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio
8.15.5 SUNΛ Med-Engineering Recent Developments
8.16 Starleaf
8.16.1 Starleaf Comapny Information
8.16.2 Starleaf Business Overview
8.16.3 Starleaf Ultrasonic Microbubble Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio
8.16.5 Starleaf Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Ultrasonic Microbubble Contrast Agents Value Chain Analysis
9.1.1 Ultrasonic Microbubble Contrast Agents Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Ultrasonic Microbubble Contrast Agents Production Mode & Process
9.2 Ultrasonic Microbubble Contrast Agents Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Ultrasonic Microbubble Contrast Agents Distributors
9.2.3 Ultrasonic Microbubble Contrast Agents Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings